Hhr Asset Management, LLC Crispr Therapeutics Ag Transaction History

Hhr Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $3.92 Million - $7.43 Million	-35,370 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $976,754 - $2.12 Million	-12,260 Reduced 25.74%	35,370 $5.42 Million
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $293,590 - $376,393	-3,740 Reduced 7.28%	47,630 $3.98 Million
Q2 2020 Aug 07, 2020	SELL	$38.5 - $76.05 $281,050 - $555,165	-7,300 Reduced 12.44%	51,370 $3.78 Million
Q4 2019 Feb 14, 2020	SELL	$36.68 - $73.13 $214,944 - $428,541	-5,860 Reduced 9.08%	58,670 $3.57 Million
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $2.29 Million - $3.11 Million	64,530 New	64,530 $3.04 Million

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Hhr Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hhr Asset Management, LLC with notifications on news.